Jonathan Weissman, MIT
Exclusive: Big-name academics and investors are quietly preparing a slate of new (epi)genome editing companies
A few weeks after Jennifer Doudna introduced CRISPR/Cas9 genome editing to the world, one of her old students decided to take the central part of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
